Neurotensin Modulates the Migratory and Inflammatory Response of Macrophages under Hyperglycemic Conditions

被引:18
作者
Moura, Liane I. F. [1 ,2 ]
Silva, Lucilia [1 ]
Leal, Ermelindo C. [1 ]
Tellechea, Ana [1 ,3 ]
Cruz, Maria Teresa [1 ,3 ]
Carvalho, Eugenia [1 ,4 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal
[2] Univ Coimbra, FCTUC, Dept Chem Engn, CIEPQPF, P-3030790 Coimbra, Portugal
[3] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal
[4] Portuguese Diabet Assoc APDP, P-1250203 Lisbon, Portugal
关键词
RECEPTOR EXPRESSION; CYTOKINE PRODUCTION; GENE-EXPRESSION; NEUROPEPTIDE-Y; ACTIVATION; ALPHA; INVOLVEMENT; MONOCYTES; RELEASE; PEPTIDE;
D O I
10.1155/2013/941764
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Diabetic foot ulcers (DFUs) are characterized by an unsatisfactory inflammatory and migratory response. Skin inflammation involves the participation of many cells and particularly macrophages. Macrophage function can be modulated by neuropeptides; however, little is known regarding the role of neurotensin (NT) as a modulator of macrophages under inflammatory and hyperglycemic conditions. RAW 264.7 cells were maintained at 10/30 mM glucose, stimulated with/without LPS (1 mu g/mL), and treated with/without NT(10 nM). The results show that NT did not affect macrophage viability. However, NT reverted the hyperglycemia-induced impair in the migration of macrophages. The expression of IL-6 and IL-1 beta was significantly increased under 10 mM glucose in the presence of NT, while IL-1 beta and IL-12 expression significantly decreased under inflammatory and hyperglycemic conditions. More importantly, high glucose modulates NT and NT receptor expression under normal and inflammatory conditions. These results highlight the effect of NT on cell migration, which is strongly impaired under hyperglycemic conditions, as well as its effect in decreasing the proinflammatory status of macrophages under hyperglycemic and inflammatory conditions. These findings provide new insights into the potential therapeutic role of NT in chronic wounds, such as in DFU, characterized by a deficit in the migratory properties of cells and a chronic proinflammatory status.
引用
收藏
页数:13
相关论文
共 45 条
  • [11] Delgado AV, 2005, EXP BIOL MED, V230, P271
  • [12] Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -β
    Devaraj, S
    Venugopal, SK
    Singh, U
    Jialal, I
    [J]. DIABETES, 2005, 54 (01) : 85 - 91
  • [13] Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line
    Dicou, E
    Vincent, JP
    Mazella, J
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (01) : 92 - 99
  • [14] Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy
    Dvoráková, MC
    Pfeil, U
    Kuncová, J
    Svíglerová, J
    Galvis, G
    Krasteva, G
    König, P
    Grau, V
    Slavíková, J
    Kummer, W
    [J]. CELL AND TISSUE RESEARCH, 2006, 323 (03) : 383 - 393
  • [15] Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and well-being
    Elenkov, Ilia J.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (1-2) : 40 - 51
  • [16] Ganea D, 2001, ARCH IMMUNOL THER EX, V49, P101
  • [17] HARTUNG H-P, 1988, Brain Behavior and Immunity, V2, P275, DOI 10.1016/0889-1591(88)90029-3
  • [18] G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia
    Hashim, Shehla
    Li, Yuan
    Anand-Srivastava, Madhu B.
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (01) : 51 - 64
  • [19] Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes
    Hatanaka, E.
    Monteagudo, P. T.
    Marrocos, M. S. M.
    Campa, A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (03) : 443 - 447
  • [20] Mechanisms of regulation of neurotensin receptors
    Hermans, E
    Maloteaux, JM
    [J]. PHARMACOLOGY & THERAPEUTICS, 1998, 79 (02) : 89 - 104